SUMMARY
In order to contribute to a better understanding of the mechanism of action of oximes, we evaluated the affinities of 10 new oximes, derived from pyridine-imidazol bicycled systems, for human acetylcholinesterase (HssAChE) complexed with tabun, by estimating their docking energy values and comparing of the values obtained to known oximes using the software Molegro Virtual Docker (MVD)®. We evaluated the influence of the position of the oxime group as substituent in the structures and, also, the influence of the oxime group syn-anti isomery on the docking score values for all the molecules studied. Results suggest that: the affinities of the 10 new oximes for the tabun inhibited HssAChE active site are better than pralidoxime’s and similar to trimedoxime’s; the meta-pralidoxime could have more affinity for the HssAChE active site and the oximes’ anti isomers could present slightly better affinities for the HssAChE active site than the syn isomers.
KEY WORDS
acetylcholinesterase; docking studies; oximes; neurotoxic agents; theoretical calculation
REFERENCES
Bartosova L, Kuca K, Jun D, Kunesova G. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning - in vitro and in vivo testing. Internat J Tox. 24: 399-402, 2005.
[CrossRef]
Bay E, Krop S, Yates LF. Chemotherapeutic effectiveness of 1,1’-trimethylene bis (4-formylpyridinium bromide) di-oxime (TMB-4) in experimental anticholinesterase poisoning. Proc Soc Exp Biol Med. 98: 107-110, 1958.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat T N, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res. 28: 235-242, 2000.
[CrossRef]
Bernstein FC, Koetzle TF, Williams GJ, Meyer EE, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. The protein data bank. A computer-based archival file for macromolecular structures. J Mol Biol. 112: 535- 542, 1977.
[CrossRef]
Castro AT, Figueroa-Villar JD. Molecular structure, conformational analysis and charge distribution of pralidoxime: Ab initio and DFT studies. Int J Quantum Chem. 89: 135-146, 2002.
[CrossRef]
Delfino RT, Figueroa-Villar JD. Nucleophilic reactivation of sarin-inhibited acetylcholinesterase: A molecular modeling study, J Phys Chem B. 113: 8402-8411, 2009.
[CrossRef]
Delfino RT, Ribeiro TS, Figueroa-Villar JD. Organophosphorus compounds as chemical warfare agents: a review. J Braz Chem Soc. 20: 407-428, 2009.
[CrossRef]
Ekstrom F J, Astot C, Pang YP. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes, Clin Pharmacol Ther. 82: 282-293, 2007.
[CrossRef]
Frisch MJ, Trucks GW, Schlegel HB, Scuseria ES, Pople JA, Gaussian 98 (Revision A.11), Gaussian: Pittsburgh (2001).
Goncalves AS, Franca TCC, Wilter A, Figueroa-Villar JD. Molecular dynamics of the interaction of pralidoxime and deazapralidoxime with acetylcholinesterase inhibited by the neurotoxic agent tabun. J Braz Chem Soc. 17: 968-975, 2006.
[CrossRef]
Goncalves AS, França TCC, Figueroa-Villar JD, Pascutti PG. Conformational analysis of toxogonine, TMB-4 and HI-6 using PM6 and RM1 methods. J Braz Chem Soc. 21: 179-184, 2010.
[CrossRef]
Hehre WJ, Deppmeier BJ, Klunzinger PE, PC SPARTAN Pro, Wavefunction Inc.: Irvine, California (1999).
Kassa J, Kuca K, Bartosova L, Kunesova G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem. 11: 267-283, 2007.
[CrossRef]
Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel N, Silman I, Shafferman A, Sussman JL. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr. 56: 1385-1394, 2000.
Ramalho TC, Taft CA. Thermal and solvent effects on the NMR and UV parameters of some bioreductive drugs. J Chem Physics. 123: 54319-54328, 2005.
[CrossRef]
Ramalho TC, Franca TCC, Renno MN, Guimaraes AP, da Cunha EFF, Kuca K. Development of new acetylcholinesterase reactivators: Molecular modeling versus in vitro data. Chem Biol Inter. 185: 73-77, 2010.
[CrossRef]
Smirnova OI, E Gurina IL, Zhigalova V, Arestova LS. Toxicity and tolerance of toxogonin, Farmakol Toksikol. 38: 467-470, 1975.
Thomsen R, Christensen MH. MolDock: A new technique for high-accuracy molecular docking. J Med Chem. 49: 3315-3321, 2006.
[CrossRef]
Worek F, Aurbek N, Koller M, Becker C, Eyer P, Thiermann H. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates. Biochem Pharmacol. 73: 1807-1817, 2007.
[CrossRef]
|
CITED
Kaya Y, Icsel C, Yilmaz VT, Buyukgungor O. A palladium(II) complex containing both carbonyl and imine oxime ligands: Crystal structure, experimental and theoretical UV-vis, IR and NMR studies. Spectrochim Acta, Part A. 108: 133-140, 2013.
Kaya Y, Yilmaz VT, Arslan T, Buyukgungor O. Experimental and theoretical DFT studies of structure, spectroscopic and fluorescence properties of a new imine oxime derivative. J Mol Struct. 1024: 65-72, 2012.
Silva GR, Borges I, Jr., Figueroa-Villar JD, de Castro AT. Chemical defense: history, werfare agent classification and action of neurotoxic agents. Quimica Nova. 35: 2083-2091, 2012.
Matos KS, da Cunha EFF, Goncalves AD, Wilter A, Kuca K, Franca TCC, Ramalho TC. First principles calculations of thermodynamics and kinetic parameters and molecular dynamics simulations of acetylcholinesterase reactivators: can mouse data provide new insights into humans? J Biomol Struct Dyn. 30: 546-558, 2012.
Mancini DT, Matos KS, da Cunha EFF, Assis TM, Guimaraes AP, Franca TCC, Ramalho TC. Molecular modeling studies on nucleoside hydrolase from the biological warfare agent Brucella suis. J Biomol Struct Dyn. 30: 125-136, 2012.
Zdarova Karasova J, Hnidkova D, Pohanka M, Musilek K, Chilcott RP, Kuca K. Pharmacokinetics of acetylcholinesterase reactivator K203 and consequent evaluation of low molecular weight antioxidants/markers of oxidative stress. J Appl Biomed. 10: 71-78, 2012.
|
